STSS

Sharps Technology Inc
NASDAQHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$77.66M
P/E Ratio
EPS
$-63.96
Beta
2.02
52W High
$18.23
52W Low
$1.42
50-Day MA
$1.80
200-Day MA
$3.72
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About Sharps Technology Inc

Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes and sells safety syringes in the United States. The company is headquartered in Melville, New York.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)396,900
Gross Profit (TTM)-423,123
EBITDA$-16.39M
Operating Margin-2369.00%
Return on Equity-380.30%
Return on Assets-10.30%
Revenue/Share (TTM)$0.01
Book Value$4.54
Price-to-Book0.43
Price-to-Sales (TTM)195.67
EV/Revenue176.22
EV/EBITDA-2.19
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)0.00%
Shares Outstanding$42.32M
Float$36.79M
% Insiders4.55%
% Institutions24.34%

Historical Volatility

HV 10-Day
0.29%
HV 20-Day
0.28%
HV 30-Day
0.31%
HV 60-Day
11.26%
HV Rank
0.0%

Volatility is currently contracting

Latest News

Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution

NEW YORK, May 15, 2026 /PRNewswire/ -- Sharps Technology, Inc. ("STSS" or the "Company"), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the first quarter ended March 31, 2026, and provided an update on the continued execution of its treasury and infrastructure strategy. "The first quarter of 2026 shows that the strategic repositioning we completed last year is continuing to translate into meaningful financial performance," said Paul K.

PRNewsWire5/15/2026Neutral

More HEALTHCARE Stocks

Data last updated: 5/28/2026